Europe Oncology Market size surpassed USD 75.5 billion in 2021 and is estimated to witness 7% CAGR between 2022 and 2028. The market growth is owing to advancement in treatment & procedures and restructuring healthcare system for cancer during COVID-19 outbreak.
Oncology is a branch of medical science that deals with tumors including the origin, development, diagnosis, and treatment of malignant neoplasms. The tumor can be diagnosed with various imaging modalities and tests. Also, it can be treated with surgery or radiation medication such as chemotherapy and immunotherapy among others.
Get more details on this report - Request Free Sample PDF
Major drivers for Europe oncology market include rising incidence of cancer, growing geriatric population, numerous initiatives undertaken by public and private players to create disease awareness coupled with favorable reimbursement policies. Elevated consumption of alcohol and tobacco is increasing the incidence of cancer that will stimulate demand for cancer diagnostics. Furthermore, technological advancements in cancer diagnostics and treatments will accelerate adoption rate of cancer procedures.
Europe Market, By Cancer Diagnostic & Treatment
The cancer treatment segment accounted for over USD 41,228.1 million revenue in 2021. Cancer treatment plays a crucial role for almost every form of cancer. Therefore, availability of various cancer treatment option is expected to spur the segment growth. Also, the demand for cancer is rapidly increasing with the rising cancer prevalence. Further, technological advancements in treatment along with new drug development will further boost its adoption rate.
Europe Market, By Cancer Type
The breast cancer segment from Europe oncology market will cross USD 23,855 million revenue by the end of 2028. The upsurge in breast cancer cases is increasingly due to gene mutation. It is estimated that nearly 5% to 10% of breast cancer cases reported in Europe are inherited. Moreover, unhealthy lifestyle, obesity and reduced childbearing can be directly linked with breast cancer incidence, as it increases estrogen levels in the female body.
Europe Market, By End-use
The hospitals end-use segment held 67.1% Europe oncology market share in 2021, owing to availability of advanced and costly diagnostic equipment and well-trained technicians in hospital settings. Increasing elderly population base that require continuous monitoring will fuel the demand for minimally invasive diagnostic procedures and treatments performed in hospitals. Furthermore, increasing efforts in R&D for providing advanced solutions for cancer treatment will boost the cancer research institutes segment revenue.
Europe Market, By Country
Germany oncology market size was over USD 16.9 billion in 2021, attributed to rising number of initiatives to promote the value of early cancer diagnosis in delivering effective treatment. Moreover, rapidly evolving techniques in molecular biology, increasing sophistication in health care equipment and improvements & innovative approaches in technology is expected to propel the industry growth. Furthermore, factor such as high sensitivity of imaging modalities as compared to traditional diagnostics will be a major factor for the local market growth.
Competitive Industry Landscape
Major market players are Janssen Diagnostics, LLC (Johnson & Johnson), GE Healthcare, F. Hoffmann-La Roche, Bayer AG, Merck, Pfizer, Abbott, and Thermo Fischer Scientific among others. Companies engage in different organic and inorganic growth strategies to establish and strengthen their market presence in the region.